NDUFB7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.238800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.786000E-01
Normal-vs-Stage2
4.904600E-01
Normal-vs-Stage3
6.660800E-01
Normal-vs-Stage4
5.892800E-01
Stage1-vs-Stage2
4.864200E-01
Stage1-vs-Stage3
6.791600E-01
Stage1-vs-Stage4
3.523000E-01
Stage2-vs-Stage3
9.656800E-01
Stage2-vs-Stage4
6.610000E-01
Stage3-vs-Stage4
7.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.225400E-01
Normal-vs-AfricanAmerican
9.677000E-01
Normal-vs-Asian
1.678600E-01
Caucasian-vs-AfricanAmerican
2.435600E-01
Caucasian-vs-Asian
4.742000E-02
AfricanAmerican-vs-Asian
5.898400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.446800E-01
Normal-vs-Female
3.950600E-01
Male-vs-Female
6.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.450000E-01
Normal-vs-Age(41-60Yrs)
5.771000E-01
Normal-vs-Age(61-80Yrs)
3.994600E-01
Normal-vs-Age(81-100Yrs)
9.284400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.527200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.597200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.483600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.770800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.331800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.701400E-01
Normal-vs-Daily Drinker
3.426000E-01
Normal-vs-Weekly Drinker
2.157600E-01
Normal-vs-Occasional Drinker
4.081600E-01
Normal-vs-Social Drinker
4.674800E-01
Non Drinker-vs-Daily Drinker
1.456000E-01
Non Drinker-vs-Weekly Drinker
1.627640E-01
Non Drinker-vs-Occasional Drinker
7.309200E-01
Non Drinker-vs-Social Drinker
9.586000E-01
Daily Drinker-vs-Weekly Drinker
8.495000E-01
Daily Drinker-vs-Occasional Drinker
2.524400E-01
Daily Drinker-vs-Social Drinker
1.978550E-01
Weekly Drinker-vs-Occasional Drinker
2.878600E-01
Weekly Drinker-vs-Social Drinker
2.274400E-01
Occasional Drinker-vs-Social Drinker
8.268000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.157000E-01
Normal-vs-Grade 2
2.080800E-01
Normal-vs-Grade 3
3.346400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.685400E-01
Grade 1-vs-Grade 3
2.315400E-01
Grade 1-vs-Grade 4
4.157000E-01
Grade 2-vs-Grade 3
4.391800E-01
Grade 2-vs-Grade 4
2.080800E-01
Grade 3-vs-Grade 4
3.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.334200E-01
Normal-vs-NonDiabetic
3.411000E-01
Diabetic-vs-NonDiabetic
5.495800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.911600E-02
Normal-vs-NoPancreatitis
3.615800E-01
Pancreatitis-vs-NoPancreatitis
3.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.766600E-01
Normal-vs-N1
5.214800E-01
N0-vs-N1
1.588440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.510600E-01
Normal-vs-TP53-NonMutant
7.450800E-01
TP53-Mutant-vs-TP53-NonMutant
7.158800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
